Steris (STE) Free Cash Flow (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.91% |
| Dec 31, 2025 | -0.89% |
| Sep 30, 2025 | -38.33% |
| Jun 30, 2025 | 71.88% |
| Mar 31, 2025 | -22.05% |
| Dec 31, 2024 | 63.60% |
| Sep 30, 2024 | -23.88% |
| Jun 30, 2024 | 19.77% |
| Mar 31, 2024 | -5.22% |
| Dec 31, 2023 | 174.36% |
| Sep 30, 2023 | -70.73% |
| Jun 30, 2023 | 48.62% |
| Mar 31, 2023 | 26.89% |
| Dec 31, 2022 | 440.27% |
| Sep 30, 2022 | -81.82% |
| Jun 30, 2022 | 17.39% |
| Mar 31, 2022 | -39.54% |
| Dec 31, 2021 | 72.93% |
| Sep 30, 2021 | 130.00% |
| Jun 30, 2021 | -63.72% |
| Mar 31, 2021 | -25.58% |
| Dec 31, 2020 | 28.71% |
| Sep 30, 2020 | 75.53% |
| Jun 30, 2020 | -51.39% |
| Mar 31, 2020 | 82.43% |
| Dec 31, 2019 | -25.85% |
| Sep 30, 2019 | 71.79% |
| Jun 30, 2019 | -41.88% |
| Mar 31, 2019 | 23.15% |
| Dec 31, 2018 | -8.68% |
| Sep 30, 2018 | 24.70% |